One Tirzepatide Injection + Lifestyle and Nutrition Consultation
What is Tirzepatide?
Tirzepatide injection is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist originally approved for the treatment of type 2 diabetes. It functions by mimicking a hormone that targets areas of the brain involved in appetite regulation.
How does Tirzepatide work?
Tirzepatide works by mimicking the GLP-1 and GIP hormones that are naturally secreted by the intestine after a meal, which prompts insulin secretion. It also reduces appetite by slowing down the time it takes the stomach to empty and interacting with areas in the brain harboring GLP-1 receptors to signal satiety. By slowing gastric emptying, enhancing feelings of fullness, and reducing appetite, Tirzepatide helps manage weight when combined with diet and exercise.
How much weight is lost on Tirzepatide?
Patients on Tirzepatide 5mg weekly lost 16.1 kg (35.5 lb) on average after 72 weeks. For Tirzepatide's 10mg weekly dose, the average weight loss was 22.2 kg (48.9 lb), and for Tirzepatide's 15mg weekly dose average weight loss was 23.6 kg (52.0 lb) over 72 weeks. Patients who used a placebo lost 2.4 kg (5.3 lb) over the 72 weeks. These results are from the clinical trial SURMOUNT-1, NCT04184622. Individual results may vary.
What are the side effects of tirzepatide?
Common tirzepatide side effects
The most common tirzepatide side effects include abdominal pain, burping, constipation, diarrhea, dyspepsia, fatigue, gastroesophageal reflux disease, hair loss, hypersensitivity reactions, injection site reactions, nausea, and vomiting, which affects 5% or more patients.
Serious tirzepatide side effects
Stop using this medicine and get emergency medical help if you have:
signs of an allergic reaction: hives; difficulty breathing; feeling light-headed; swelling of your face, lips, tongue, or throat; or
pancreatitis with symptoms of severe pain in your upper stomach spreading to your back, nausea, and vomiting.
Call your doctor at once if you have:
severe stomach problems;
eye side effects or vision changes, including blurry vision or blurred vision;
signs of a thyroid tumor symptoms may include swelling or a lump in your neck, trouble swallowing, a hoarse voice, or if you feel short of breath;
gallbladder problem with symptoms including chalky-colored stools, stomach pain after eating, nausea, heartburn, bloating, and severe upper stomach pain that may spread to your back;
low blood sugar symptoms may include headache, hunger, weakness, sweating, confusion, irritability, dizziness, fast heart rate, or feeling jittery or
kidney problems with little or no urination, swelling in your feet or ankles, feeling tired or short of breath.
This is not a complete list of side effects, and others may occur. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
How should I use tirzepatide?
You should follow the directions on your prescription label carefully and ask your pharmacist or doctor to explain any part you do not understand. It is important to use this medicine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Tirzepatide is injected under the skin (subcutaneously) using a pre-filled pen or a single-dose vial with a syringe. Caregivers or patients should be trained on proper injection techniques. When using single-dose vials, a 1 mL syringe capable of measuring a 0.5 mL dose must be used for dose administration.
It is usually given
once a week.
can be given with or without meals at any time of the day.
may be injected into the thigh, abdomen, or upper arm.
You should rotate injection sites with each dose.
Your doctor will probably start you on a low dose, which may be gradually increased, but not more than once every 4 weeks.
You may change the day of the week you use tirzepatide as long as there are at least three days between doses.
You may administer insulin in the same area as tirzepatide, but they should not be given right next to each other. Insulin and tirzepatide should be given as separate injections and not be mixed in the same injection.
What is Tirzepatide?
Tirzepatide injection is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist originally approved for the treatment of type 2 diabetes. It functions by mimicking a hormone that targets areas of the brain involved in appetite regulation.
How does Tirzepatide work?
Tirzepatide works by mimicking the GLP-1 and GIP hormones that are naturally secreted by the intestine after a meal, which prompts insulin secretion. It also reduces appetite by slowing down the time it takes the stomach to empty and interacting with areas in the brain harboring GLP-1 receptors to signal satiety. By slowing gastric emptying, enhancing feelings of fullness, and reducing appetite, Tirzepatide helps manage weight when combined with diet and exercise.
How much weight is lost on Tirzepatide?
Patients on Tirzepatide 5mg weekly lost 16.1 kg (35.5 lb) on average after 72 weeks. For Tirzepatide's 10mg weekly dose, the average weight loss was 22.2 kg (48.9 lb), and for Tirzepatide's 15mg weekly dose average weight loss was 23.6 kg (52.0 lb) over 72 weeks. Patients who used a placebo lost 2.4 kg (5.3 lb) over the 72 weeks. These results are from the clinical trial SURMOUNT-1, NCT04184622. Individual results may vary.
What are the side effects of tirzepatide?
Common tirzepatide side effects
The most common tirzepatide side effects include abdominal pain, burping, constipation, diarrhea, dyspepsia, fatigue, gastroesophageal reflux disease, hair loss, hypersensitivity reactions, injection site reactions, nausea, and vomiting, which affects 5% or more patients.
Serious tirzepatide side effects
Stop using this medicine and get emergency medical help if you have:
signs of an allergic reaction: hives; difficulty breathing; feeling light-headed; swelling of your face, lips, tongue, or throat; or
pancreatitis with symptoms of severe pain in your upper stomach spreading to your back, nausea, and vomiting.
Call your doctor at once if you have:
severe stomach problems;
eye side effects or vision changes, including blurry vision or blurred vision;
signs of a thyroid tumor symptoms may include swelling or a lump in your neck, trouble swallowing, a hoarse voice, or if you feel short of breath;
gallbladder problem with symptoms including chalky-colored stools, stomach pain after eating, nausea, heartburn, bloating, and severe upper stomach pain that may spread to your back;
low blood sugar symptoms may include headache, hunger, weakness, sweating, confusion, irritability, dizziness, fast heart rate, or feeling jittery or
kidney problems with little or no urination, swelling in your feet or ankles, feeling tired or short of breath.
This is not a complete list of side effects, and others may occur. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
How should I use tirzepatide?
You should follow the directions on your prescription label carefully and ask your pharmacist or doctor to explain any part you do not understand. It is important to use this medicine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Tirzepatide is injected under the skin (subcutaneously) using a pre-filled pen or a single-dose vial with a syringe. Caregivers or patients should be trained on proper injection techniques. When using single-dose vials, a 1 mL syringe capable of measuring a 0.5 mL dose must be used for dose administration.
It is usually given
once a week.
can be given with or without meals at any time of the day.
may be injected into the thigh, abdomen, or upper arm.
You should rotate injection sites with each dose.
Your doctor will probably start you on a low dose, which may be gradually increased, but not more than once every 4 weeks.
You may change the day of the week you use tirzepatide as long as there are at least three days between doses.
You may administer insulin in the same area as tirzepatide, but they should not be given right next to each other. Insulin and tirzepatide should be given as separate injections and not be mixed in the same injection.
What is Tirzepatide?
Tirzepatide injection is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist originally approved for the treatment of type 2 diabetes. It functions by mimicking a hormone that targets areas of the brain involved in appetite regulation.
How does Tirzepatide work?
Tirzepatide works by mimicking the GLP-1 and GIP hormones that are naturally secreted by the intestine after a meal, which prompts insulin secretion. It also reduces appetite by slowing down the time it takes the stomach to empty and interacting with areas in the brain harboring GLP-1 receptors to signal satiety. By slowing gastric emptying, enhancing feelings of fullness, and reducing appetite, Tirzepatide helps manage weight when combined with diet and exercise.
How much weight is lost on Tirzepatide?
Patients on Tirzepatide 5mg weekly lost 16.1 kg (35.5 lb) on average after 72 weeks. For Tirzepatide's 10mg weekly dose, the average weight loss was 22.2 kg (48.9 lb), and for Tirzepatide's 15mg weekly dose average weight loss was 23.6 kg (52.0 lb) over 72 weeks. Patients who used a placebo lost 2.4 kg (5.3 lb) over the 72 weeks. These results are from the clinical trial SURMOUNT-1, NCT04184622. Individual results may vary.
What are the side effects of tirzepatide?
Common tirzepatide side effects
The most common tirzepatide side effects include abdominal pain, burping, constipation, diarrhea, dyspepsia, fatigue, gastroesophageal reflux disease, hair loss, hypersensitivity reactions, injection site reactions, nausea, and vomiting, which affects 5% or more patients.
Serious tirzepatide side effects
Stop using this medicine and get emergency medical help if you have:
signs of an allergic reaction: hives; difficulty breathing; feeling light-headed; swelling of your face, lips, tongue, or throat; or
pancreatitis with symptoms of severe pain in your upper stomach spreading to your back, nausea, and vomiting.
Call your doctor at once if you have:
severe stomach problems;
eye side effects or vision changes, including blurry vision or blurred vision;
signs of a thyroid tumor symptoms may include swelling or a lump in your neck, trouble swallowing, a hoarse voice, or if you feel short of breath;
gallbladder problem with symptoms including chalky-colored stools, stomach pain after eating, nausea, heartburn, bloating, and severe upper stomach pain that may spread to your back;
low blood sugar symptoms may include headache, hunger, weakness, sweating, confusion, irritability, dizziness, fast heart rate, or feeling jittery or
kidney problems with little or no urination, swelling in your feet or ankles, feeling tired or short of breath.
This is not a complete list of side effects, and others may occur. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
How should I use tirzepatide?
You should follow the directions on your prescription label carefully and ask your pharmacist or doctor to explain any part you do not understand. It is important to use this medicine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Tirzepatide is injected under the skin (subcutaneously) using a pre-filled pen or a single-dose vial with a syringe. Caregivers or patients should be trained on proper injection techniques. When using single-dose vials, a 1 mL syringe capable of measuring a 0.5 mL dose must be used for dose administration.
It is usually given
once a week.
can be given with or without meals at any time of the day.
may be injected into the thigh, abdomen, or upper arm.
You should rotate injection sites with each dose.
Your doctor will probably start you on a low dose, which may be gradually increased, but not more than once every 4 weeks.
You may change the day of the week you use tirzepatide as long as there are at least three days between doses.
You may administer insulin in the same area as tirzepatide, but they should not be given right next to each other. Insulin and tirzepatide should be given as separate injections and not be mixed in the same injection.